125 related articles for article (PubMed ID: 31201002)
21. Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report.
Utsumi M; Tanakaya K; Mushiake Y; Kunitomo T; Yasuhara I; Taniguchi F; Arata T; Katsuda K; Aoki H; Takeuchi H
World J Surg Oncol; 2017 Aug; 15(1):140. PubMed ID: 28764791
[TBL] [Abstract][Full Text] [Related]
22. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer imaging: a challenge for radiologists.
Stevenson GW
Radiology; 2000 Mar; 214(3):615-21. PubMed ID: 10715019
[No Abstract] [Full Text] [Related]
24. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
25. Lynch syndrome (HNPCC) and microsatellite instability.
Umar A
Dis Markers; 2004; 20(4-5):179-80. PubMed ID: 15528783
[No Abstract] [Full Text] [Related]
26. Neoadjuvant therapy in microsatellite-stable colorectal carcinoma induces concomitant loss of MSH6 and Ki-67 expression.
Kuan SF; Ren B; Brand R; Dudley B; Pai RK
Hum Pathol; 2017 May; 63():33-39. PubMed ID: 28232158
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
28. Lynch Syndrome-Related Clear Cell Carcinoma of the Cervix: A Case Report.
Nakamura K; Nakayama K; Minamoto T; Ishibashi T; Ohnishi K; Yamashita H; Ono R; Sasamori H; Razia S; Hossain MM; Kamrunnahar S; Ishikawa M; Ishikawa N; Kyo S
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587389
[TBL] [Abstract][Full Text] [Related]
29. A rare case of primary adenosquamous carcinoma of the liver with gallbladder metastasis.
Wu PH; Su YC; Kuo KK
Kaohsiung J Med Sci; 2020 Jul; 36(7):561-562. PubMed ID: 32449238
[No Abstract] [Full Text] [Related]
30. Detecting Lynch syndrome by pathologists.
van Krieken JH; Kets CM; Ligtenberg MJ; Hoogerbrugge N
Verh Dtsch Ges Pathol; 2007; 91():104-11. PubMed ID: 18314603
[TBL] [Abstract][Full Text] [Related]
31. Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome.
Hansen MF; Johansen J; Sylvander AE; Bjørnevoll I; Talseth-Palmer BA; Lavik LAS; Xavier A; Engebretsen LF; Scott RJ; Drabløs F; Sjursen W
Clin Genet; 2017 Oct; 92(4):405-414. PubMed ID: 28195393
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability and colorectal cancer.
Geiersbach KB; Samowitz WS
Arch Pathol Lab Med; 2011 Oct; 135(10):1269-77. PubMed ID: 21970482
[TBL] [Abstract][Full Text] [Related]
33. Stability of BAT26 in Lynch syndrome colorectal tumours.
Jaskowski L; Young J; Jackson L; Arnold S; Barker MA; Walsh MD; Buchanan DD; Holman S; Mensink KA; Jenkins MA; Hopper JL; Thibodeau SN; Jass JR; Spurdle AB
Eur J Hum Genet; 2007 Feb; 15(2):139-41; author reply 141-2. PubMed ID: 17133259
[No Abstract] [Full Text] [Related]
34. Molecular screening for the Lynch syndrome--better than family history?
Lynch HT; Lynch PM
N Engl J Med; 2005 May; 352(18):1920-2. PubMed ID: 15872208
[No Abstract] [Full Text] [Related]
35. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
36. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
37. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
[TBL] [Abstract][Full Text] [Related]
38. Surgical management of hereditary colorectal cancer: surgery based on molecular analysis and family history.
Perea J; Justo I; Alvaro E; Lomas M; Tasende JD; Marín JC; Franco A; Colina F; Rodríguez Y; Martínez J; Robles L; Urioste M; Hidalgo M
Rev Esp Enferm Dig; 2009 Aug; 101(8):536-40. PubMed ID: 19785492
[TBL] [Abstract][Full Text] [Related]
39. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.
Abu Freha N; Leibovici Weissman Y; Fich A; Barnes Kedar I; Halpern M; Sztarkier I; Behar DM; Arbib Sneh O; Vilkin A; Baris HN; Gingold R; Lejbkowicz F; Niv Y; Goldberg Y; Levi Z
Fam Cancer; 2018 Jan; 17(1):79-86. PubMed ID: 28608265
[TBL] [Abstract][Full Text] [Related]
40. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
Kravochuck SE; Church JM
ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
